Nunery W R, Welsh M G, McCord C D
Am J Ophthalmol. 1983 Jul;96(1):10-5. doi: 10.1016/0002-9394(83)90449-x.
Sebaceous carcinoma originating in the meibomian gland recurred in six patients (four women, 61, 68, 71, and 88 years old, and two men, 52 and 65 years old) who had undergone radiation therapy. The patients had received radiation dosages ranging from 3,300 to 11,900 rads. The tumors recurred two months to two years after treatment. All six patients then underwent surgical excision of the tumors and have remained tumor-free for follow-up periods of as long as 42 months. These data indicated that radiation therapy of sebaceous carcinoma of the eyelid should be considered palliative rather than curative.
6例曾接受放射治疗的睑板腺皮脂腺癌患者（4名女性，年龄分别为61、68、71和88岁；2名男性，年龄分别为52和65岁）出现复发。这些患者接受的放射剂量在3300至11900拉德之间。肿瘤在治疗后2个月至2年复发。随后，所有6例患者均接受了肿瘤手术切除，在长达42个月的随访期内均未再出现肿瘤。这些数据表明，眼睑皮脂腺癌的放射治疗应被视为姑息性而非根治性治疗。
